$MFIN
MEDALLION FINANCIAL CORP

2021 Q4 Form 10-Q Financial Statement

#000095017021003478 Filed on November 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $41.50M $37.44M
YoY Change 10.84% 8.08%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.230M $1.210M $2.130M
YoY Change -53.58% -43.19% 17.03%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $7.426M $8.384M
YoY Change -11.43% -9.12%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $27.91M $22.89M -$28.41M
YoY Change 158.43% -180.56% -473.87%
Income Tax $7.640M $6.167M -$8.381M
% Of Pretax Income 27.37% 26.94%
Net Earnings $19.47M $15.94M -$23.63M
YoY Change 200.93% -167.46% -574.97%
Net Earnings / Revenue 38.41% -63.11%
Basic Earnings Per Share $0.65 -$0.97
Diluted Earnings Per Share $780.7K $0.64 -$0.97
COMMON SHARES
Basic Shares Outstanding 25.08M 24.63M 24.46M
Diluted Shares Outstanding 24.99M 24.46M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $109.3M $78.20M
YoY Change 7.6%
Cash & Equivalents $64.48M $30.69M $12.59M
Short-Term Investments $44.77M $47.51M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $11.80M $11.70M $12.60M
YoY Change -4.84% -7.14% -6.67%
Goodwill $150.8M $150.8M $150.8M
YoY Change 0.0% 0.0% 0.0%
Intangibles $23.48M $50.01M $51.45M
YoY Change -54.04% -2.81% -2.73%
Long-Term Investments $9.726M $0.00 $10.30M
YoY Change -0.21% -100.0% 4.25%
Other Assets $1.600M
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.873B $1.805B $1.604B
YoY Change 14.04% 12.53% 5.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.400M $3.000M $3.800M
YoY Change -27.66% -21.05% 8.57%
Accrued Expenses $11.20M $11.50M $13.20M
YoY Change -13.85% -12.88% -5.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $8.054M $87.70M
YoY Change -100.0% -90.82% 106.33%
Long-Term Debt Due $0.00 $8.100M $87.70M
YoY Change -100.0% -90.76%
Total Short-Term Liabilities $24.80M $40.60M $124.5M
YoY Change -78.09% -67.39% 305.54%
LONG-TERM LIABILITIES
Long-Term Debt $220.0M $213.9M $121.2M
YoY Change 43.14% 76.49% -33.26%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $220.0M $213.9M $121.2M
YoY Change 43.14% 76.49% -33.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.80M $40.60M $124.5M
Total Long-Term Liabilities $220.0M $213.9M $121.2M
Total Liabilities $1.517B $1.467B $1.307B
YoY Change 13.41% 12.21% 6.53%
SHAREHOLDERS EQUITY
Retained Earnings $30.61M $11.14M -$29.97M
YoY Change -230.23% -137.16% -355.14%
Common Stock $280.3M $279.7M $277.3M
YoY Change 0.9% 0.88% 0.68%
Preferred Stock
YoY Change
Treasury Stock (at cost) $24.92M $24.92M $24.92M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $2.951M $2.951M $2.951M
Shareholders Equity $287.0M $267.2M $224.5M
YoY Change
Total Liabilities & Shareholders Equity $1.873B $1.805B $1.604B
YoY Change 14.04% 12.53% 5.56%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $19.47M $15.94M -$23.63M
YoY Change 200.93% -167.46% -574.97%
Depreciation, Depletion And Amortization $1.230M $1.210M $2.130M
YoY Change -53.58% -43.19% 17.03%
Cash From Operating Activities $16.75M $22.16M $23.17M
YoY Change -24.35% -4.36% 153.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$36.19M -$70.32M -$51.16M
YoY Change -5667.69% 37.45% -10.96%
Cash From Investing Activities -$36.19M -$70.32M -$51.16M
YoY Change -5667.69% 37.45% -10.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 58.56M 41.98M -26.16M
YoY Change 48.18% -260.47% -183.87%
NET CHANGE
Cash From Operating Activities 16.75M 22.16M 23.17M
Cash From Investing Activities -36.19M -70.32M -51.16M
Cash From Financing Activities 58.56M 41.98M -26.16M
Net Change In Cash 39.12M -6.180M -54.15M
YoY Change -37.22% -88.59% 216.11%
FREE CASH FLOW
Cash From Operating Activities $16.75M $22.16M $23.17M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2027-12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001000209
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-02-28
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P42M
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37747
dei Entity Registrant Name
EntityRegistrantName
MEDALLION FINANCIAL CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3291176
dei Entity Address Address Line1
EntityAddressAddressLine1
437 MADISON AVENUE, 38th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
NEW YORK
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
328-2100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
MFIN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25078944
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30688000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54743000
CY2021Q3 us-gaap Federal Funds Sold
FederalFundsSold
54686000
CY2020Q4 us-gaap Federal Funds Sold
FederalFundsSold
57297000
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
47511000
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
46792000
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
10214000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9746000
CY2021Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1419681000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1229838000
CY2021Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
47448000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57548000
CY2021Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1372233000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1172290000
CY2021Q3 us-gaap Goodwill
Goodwill
150803000
CY2020Q4 us-gaap Goodwill
Goodwill
150803000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50007000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51090000
CY2021Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
42544000
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
54560000
CY2021Q3 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
11741000
CY2020Q4 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
12404000
CY2021Q3 us-gaap Interest Receivable
InterestReceivable
9646000
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
10338000
CY2021Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
540000
CY2020Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
1757000
CY2021Q3 us-gaap Other Assets
OtherAssets
24621000
CY2020Q4 us-gaap Other Assets
OtherAssets
20591000
CY2021Q3 us-gaap Assets
Assets
1805234000
CY2020Q4 us-gaap Assets
Assets
1642411000
CY2021Q3 us-gaap Deposits
Deposits
1196508000
CY2020Q4 us-gaap Deposits
Deposits
1065398000
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
213858000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
153718000
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12703000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
807000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9346000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11018000
CY2021Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
8054000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
87334000
CY2021Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
3047000
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4673000
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
23106000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
14902000
CY2021Q3 us-gaap Liabilities
Liabilities
1466622000
CY2020Q4 us-gaap Liabilities
Liabilities
1337850000
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28033404
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27828871
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
280000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
278000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
279454000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
277539000
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2951243
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2951243
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
24919000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
24919000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1293000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2012000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11136000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23502000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
267244000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
231408000
CY2021Q3 us-gaap Minority Interest
MinorityInterest
71368000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
73153000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
338612000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
304561000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1805234000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1642411000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25082161
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24877628
CY2021Q3 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.65
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.30
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
2970000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
2970000
CY2021Q3 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
4793000
CY2020Q4 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
3535000
CY2021Q3 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2140000
CY2020Q4 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2004000
CY2021Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
41250000
CY2020Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
37201000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
115237000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
107544000
CY2021Q3 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
247000
CY2020Q3 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
239000
mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
716000
mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
973000
us-gaap Lease Income
LeaseIncome
53000
CY2021Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
41497000
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
37440000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
115953000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
108570000
CY2021Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
4189000
CY2020Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
5454000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
13366000
us-gaap Interest Expense Deposits
InterestExpenseDeposits
17315000
CY2021Q3 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
39000
CY2020Q3 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
520000
us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
690000
us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
1565000
CY2021Q3 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
3198000
CY2020Q3 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
2410000
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
9662000
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
7339000
CY2021Q3 us-gaap Interest Expense
InterestExpense
7426000
CY2020Q3 us-gaap Interest Expense
InterestExpense
8384000
us-gaap Interest Expense
InterestExpense
23718000
us-gaap Interest Expense
InterestExpense
26219000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
34071000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
29056000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
92235000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
82351000
CY2021Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-337000
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
39749000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2000000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
73231000
CY2021Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
34408000
CY2020Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-10693000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
90235000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
9120000
CY2021Q3 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
3335000
CY2020Q3 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
8962000
mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
10153000
mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
15161000
CY2021Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
4101000
CY2020Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
137000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
7306000
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-3423000
CY2021Q3 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
438000
CY2020Q3 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
8559000
mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
5385000
mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
15828000
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
23000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4626000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
23000
CY2021Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
208000
CY2020Q3 us-gaap Noninterest Income Other
NoninterestIncomeOther
397000
us-gaap Noninterest Income Other
NoninterestIncomeOther
209000
us-gaap Noninterest Income Other
NoninterestIncomeOther
1303000
CY2021Q3 us-gaap Noninterest Income
NoninterestIncome
7206000
CY2020Q3 us-gaap Noninterest Income
NoninterestIncome
960000
us-gaap Noninterest Income
NoninterestIncome
16909000
us-gaap Noninterest Income
NoninterestIncome
-2764000
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7957000
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7081000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
21542000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
20716000
CY2021Q3 mfin Race Team Related Expense
RaceTeamRelatedExpense
2424000
CY2020Q3 mfin Race Team Related Expense
RaceTeamRelatedExpense
2636000
mfin Race Team Related Expense
RaceTeamRelatedExpense
7219000
mfin Race Team Related Expense
RaceTeamRelatedExpense
6584000
CY2021Q3 mfin Loan Servicing Fee
LoanServicingFee
1684000
CY2020Q3 mfin Loan Servicing Fee
LoanServicingFee
1729000
mfin Loan Servicing Fee
LoanServicingFee
5062000
mfin Loan Servicing Fee
LoanServicingFee
5070000
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
1963000
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
1651000
us-gaap Professional Fees
ProfessionalFees
4694000
us-gaap Professional Fees
ProfessionalFees
6559000
CY2021Q3 mfin Collection Costs
CollectionCosts
1136000
CY2020Q3 mfin Collection Costs
CollectionCosts
1516000
mfin Collection Costs
CollectionCosts
4010000
mfin Collection Costs
CollectionCosts
4206000
CY2021Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
481000
CY2020Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
676000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1780000
mfin Travel Meals And Entertainment Expense
TravelMealsAndEntertainmentExpense
303000
mfin Travel Meals And Entertainment Expense
TravelMealsAndEntertainmentExpense
404000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2004000
CY2021Q3 mfin Regulatory Fees
RegulatoryFees
488000
CY2020Q3 mfin Regulatory Fees
RegulatoryFees
348000
mfin Regulatory Fees
RegulatoryFees
1383000
mfin Regulatory Fees
RegulatoryFees
949000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
362000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
362000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1083000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1084000
CY2021Q3 mfin Travel Meals And Entertainment Expense
TravelMealsAndEntertainmentExpense
175000
CY2020Q3 mfin Travel Meals And Entertainment Expense
TravelMealsAndEntertainmentExpense
64000
CY2021Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2053000
CY2020Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2618000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
6008000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
6663000
CY2021Q3 us-gaap Noninterest Expense
NoninterestExpense
18723000
CY2020Q3 us-gaap Noninterest Expense
NoninterestExpense
18681000
us-gaap Noninterest Expense
NoninterestExpense
53185000
us-gaap Noninterest Expense
NoninterestExpense
54138000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22891000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28414000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
53959000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47782000
CY2021Q3 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
6167000
CY2020Q3 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
-8381000
mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
16573000
mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
-12483000
CY2021Q3 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
16724000
CY2020Q3 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
-20033000
mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
37386000
mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
-35299000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
784000
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3597000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2748000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5951000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
15940000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-23630000
us-gaap Net Income Loss
NetIncomeLoss
34638000
us-gaap Net Income Loss
NetIncomeLoss
-41250000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.39
CY2021Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1511000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24634845
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24461488
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24583573
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24440067
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24990226
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24461488
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24945707
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24440067
CY2021Q3 us-gaap Paid In Kind Interest
PaidInKindInterest
188000
us-gaap Paid In Kind Interest
PaidInKindInterest
682000
CY2020Q3 us-gaap Paid In Kind Interest
PaidInKindInterest
306000
us-gaap Paid In Kind Interest
PaidInKindInterest
940000
CY2021Q3 mfin Average Borrowings Outstanding
AverageBorrowingsOutstanding
1391350000
mfin Average Borrowings Outstanding
AverageBorrowingsOutstanding
1342581000
CY2021Q3 mfin Weighted Average Cost Of Borrowings
WeightedAverageCostOfBorrowings
0.0212
mfin Weighted Average Cost Of Borrowings
WeightedAverageCostOfBorrowings
0.0236
CY2020Q3 mfin Average Borrowings Outstanding
AverageBorrowingsOutstanding
1309787000
mfin Average Borrowings Outstanding
AverageBorrowingsOutstanding
1255053000
CY2020Q3 mfin Weighted Average Cost Of Borrowings
WeightedAverageCostOfBorrowings
0.0255
mfin Weighted Average Cost Of Borrowings
WeightedAverageCostOfBorrowings
0.0279
CY2021Q3 us-gaap Profit Loss
ProfitLoss
16724000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-20033000
us-gaap Profit Loss
ProfitLoss
37386000
us-gaap Profit Loss
ProfitLoss
-35299000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-141000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-53000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-719000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1075000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
16583000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-20086000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
36667000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34224000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
784000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3597000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2748000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
5951000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15799000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23683000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33919000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40175000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
304561000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9071000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
498000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2021Q1 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-605000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
312014000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
11592000
CY2021Q2 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1511000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
576000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
116000
CY2021Q2 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
27000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
322814000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
16724000
CY2021Q3 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
602000
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
125000
CY2021Q3 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-141000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
338612000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
334468000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-13001000
CY2020Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1507000
CY2020Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1507000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
466000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2020Q1 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
147000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
320573000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-2265000
CY2020Q2 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2020Q2 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
520000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2020Q2 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
981000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
318297000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-20033000
CY2020Q3 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
508000
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2020Q3 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-53000
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
297207000
us-gaap Profit Loss
ProfitLoss
37386000
us-gaap Profit Loss
ProfitLoss
-35299000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
2000000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
73231000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
682000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
940000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5289000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5060000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
13113000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-11113000
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-5770000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-504000
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-4572000
mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-8501000
mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-21235000
mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
7436000
mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
-3754000
us-gaap Share Based Compensation
ShareBasedCompensation
1674000
us-gaap Share Based Compensation
ShareBasedCompensation
1495000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4626000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-692000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
1928000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1577000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7878000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3498000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4883000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1626000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
61976000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56568000
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
564914000
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
404006000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
342718000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
222592000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
17979000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
11480000
us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
21389000
us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
12983000
mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
16661000
mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
8303000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-202125000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-171608000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
587945000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
515982000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
470168000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
414501000
mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
4534000
mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
4531000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
240000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113483000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96950000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26666000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-18090000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
112040000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67821000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
85374000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49731000
us-gaap Interest Paid Net
InterestPaidNet
23418000
us-gaap Interest Paid Net
InterestPaidNet
24769000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3150000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
100000
mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
13145000
mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
25569000
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
0
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
1800000
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
8689000
mfin Number Of Medallions
NumberOfMedallions
159
CY2021Q3 us-gaap Reorganization Value Net Realizable Value Of Asset Dispositions
ReorganizationValueNetRealizableValueOfAssetDispositions
1069875
CY2020Q4 us-gaap Reorganization Value Net Realizable Value Of Asset Dispositions
ReorganizationValueNetRealizableValueOfAssetDispositions
2932000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the US, or GAAP, requires management to make estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions change, it is reasonably possible that</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">judgments and estimates could change, which may result in future impairments of loans and loan collateral in process of foreclosure, goodwill and intangible assets, and investments, among other effects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1250000
CY2021Q3 mfin Non Marketable Securities
NonMarketableSecurities
10214000
CY2020Q4 mfin Non Marketable Securities
NonMarketableSecurities
9746000
CY2021Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1166667
CY2021Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
500000
CY2021Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3816000
CY2021Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000
CY2021Q2 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
3179000
CY2021Q3 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
2727000
mfin Number Of Shares Held In Equity Securities
NumberOfSharesHeldInEquitySecurities
1000000
CY2021Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
546000
CY2021Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2021Q3 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-31000
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-0
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-31000
CY2021Q3 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
40000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
121000
CY2020Q3 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
85000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
219000
mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
25658000
CY2020 mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
20684000
CY2021Q3 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
-2037000
mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
-5757000
CY2020Q3 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
-1681000
mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
-4572000
mfin Financing Receivables Impaired Troubled Debt Restructuring Write Down As Percentage Of Loans
FinancingReceivablesImpairedTroubledDebtRestructuringWriteDownAsPercentageOfLoans
0.40
CY2021Q3 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
0
CY2020Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
15367000
CY2021Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
20477000
CY2020Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
107131000
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2021Q3 us-gaap Goodwill
Goodwill
150803000
CY2020Q4 us-gaap Goodwill
Goodwill
150803000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50007000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51090000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
362000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1083000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
362000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1084000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
50007000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51090000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
79000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
238000
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
142000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
403000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24440067
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.41
CY2021Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
576000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1814000
CY2020Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
648000
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1957000
CY2021Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7098000
CY2020Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
5805000
CY2021Q3 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
15940000
CY2020Q3 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
-23630000
mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
34638000
mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
-41250000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24634845
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24461488
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24583573
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24440067
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
98906
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
82522
CY2021Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
256475
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
279612
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24990226
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24461488
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24945707
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.64
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
834684
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
165674
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
317398
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
335773
CY2021Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
602000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1676000
CY2021Q3 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.02
us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.07
CY2020Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
508000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1495000
CY2020Q3 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.02
us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.06
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2866000
CY2021Q2 mfin Tier One Leverage Capital Required For Capital Adequacy To Total Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToTotalAssets
0.15
CY2021Q3 mfin Tier One Leverage Capital Ratio
TierOneLeverageCapitalRatio
0.1821
CY2021Q3 us-gaap Common Equity Tier One Capital Required For Capital Adequacy
CommonEquityTierOneCapitalRequiredForCapitalAdequacy
0
CY2021Q3 us-gaap Common Equity Tier One Capital Required To Be Well Capitalized
CommonEquityTierOneCapitalRequiredToBeWellCapitalized
0
CY2021Q3 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
188459000
CY2020Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
148507000
CY2021Q3 us-gaap Tier One Risk Based Capital Required For Capital Adequacy
TierOneRiskBasedCapitalRequiredForCapitalAdequacy
0
CY2021Q3 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized
TierOneRiskBasedCapitalRequiredToBeWellCapitalized
0
CY2021Q3 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
257247000
CY2020Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
217295000
CY2021Q3 us-gaap Capital Required For Capital Adequacy
CapitalRequiredForCapitalAdequacy
0
CY2021Q3 us-gaap Capital Required To Be Well Capitalized
CapitalRequiredToBeWellCapitalized
0
CY2021Q3 us-gaap Capital
Capital
275460000
CY2020Q4 us-gaap Capital
Capital
233460000
CY2021Q3 mfin Average Assets Required For Capital Adequacy
AverageAssetsRequiredForCapitalAdequacy
0
CY2021Q3 mfin Average Assets Required To Be Well Capitalized
AverageAssetsRequiredToBeWellCapitalized
0
mfin Average Assets
AverageAssets
1412494000
CY2020 mfin Average Assets
AverageAssets
1283664000
CY2021Q3 mfin Capital Required For Capital Adequacy To Risk Weighted Assets Amount
CapitalRequiredForCapitalAdequacyToRiskWeightedAssetsAmount
0
CY2021Q3 mfin Capital Required To Be Well Capitalized To Risk Weighted Assets Amount
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssetsAmount
0
CY2021Q3 us-gaap Risk Weighted Assets
RiskWeightedAssets
1422321000
CY2020Q4 us-gaap Risk Weighted Assets
RiskWeightedAssets
1243783000
CY2021Q3 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
4.0
CY2021Q3 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
5.0
CY2021Q3 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
18.2
CY2020Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
16.9
CY2021Q3 mfin Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.070
CY2021Q3 mfin Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.065
CY2021Q3 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
13.3
CY2020Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
11.9
CY2021Q3 us-gaap Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
8.5
CY2021Q3 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
8.0
CY2021Q3 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
18.1
CY2020Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
17.5
CY2021Q3 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
10.5
CY2021Q3 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
10.0
CY2021Q3 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
19.4
CY2020Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
18.8
CY2020 mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain reclassifications have been made to prior year balances to conform with the current year presentation. These reclassifications have no effect on the previously reported results of operations.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
46873000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
992000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
354000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
47511000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
45155000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1684000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
47000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
46792000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
933000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
939000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
9969000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
10266000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
10316000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
10659000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
25655000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
25647000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
46873000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
47511000
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
353000
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
17049000
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1000
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
63000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
45000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
4028000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
196000
CY2021Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
46946000
CY2020Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
66977000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57548000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
46093000
CY2021Q3 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
3978000
CY2020Q3 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
19686000
us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
27075000
us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
38894000
CY2021Q3 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
4817000
CY2020Q3 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
3470000
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
14975000
us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
10080000
CY2021Q3 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
839000
CY2020Q3 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
16216000
us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
12100000
us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
28814000
CY2021Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-337000
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
39749000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2000000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
73231000
CY2021Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
47448000
CY2020Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
90510000
CY2021Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
47448000
CY2020Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
90510000
CY2021Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
47448000
CY2021Q3 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2021Q3 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0334
CY2021Q3 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
1.3213
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
57548000
CY2020Q4 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2020Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0468
CY2020Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
0.9317
CY2021Q3 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
35910000
CY2020Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
61767000
mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
377000
CY2020 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
2306000
mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
115000
CY2020 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
595000
mfin Interests Foregone Year To Date
InterestsForegoneYearToDate
1187000
CY2020 mfin Interests Foregone Year To Date
InterestsForegoneYearToDate
3311000
mfin Amount Of Foregone Interest Applied To Principal In The Year To Date
AmountOfForegoneInterestAppliedToPrincipalInTheYearToDate
358000
CY2020 mfin Amount Of Foregone Interest Applied To Principal In The Year To Date
AmountOfForegoneInterestAppliedToPrincipalInTheYearToDate
602000
mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
3274000
CY2020 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
5252000
mfin Amount Of Foregone Interest Applied To Principal In Life To Date
AmountOfForegoneInterestAppliedToPrincipalInLifeToDate
886000
CY2020 mfin Amount Of Foregone Interest Applied To Principal In Life To Date
AmountOfForegoneInterestAppliedToPrincipalInLifeToDate
792000
CY2021Q3 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.03
CY2020Q4 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.05
CY2021Q3 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
1.32
CY2020Q4 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
0.93
CY2021Q3 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1419681000
mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0257
CY2020Q4 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1229838000
CY2020 mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0506
mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
1469000
CY2021Q3 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
36501000
CY2021Q3 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
37387000
CY2021Q3 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
9569000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
62174000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
62778000
CY2020Q4 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
25310000
CY2021Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
38056000
CY2021Q3 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
148000
CY2020Q3 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
113759000
CY2020Q3 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
288000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
38819000
mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
425000
us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
114383000
CY2021Q3 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
28385000
CY2021Q3 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1364951000
CY2021Q3 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1393336000
CY2021Q3 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2021Q3 us-gaap Federal Home Loan Bank Advances Premium
FederalHomeLoanBankAdvancesPremium
85000
mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
25658000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
40541000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1165235000
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1205776000
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2020Q4 us-gaap Federal Home Loan Bank Advances Premium
FederalHomeLoanBankAdvancesPremium
2717000
CY2020 mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
21345000
CY2021Q3 mfin Loan To Value Ratio
LoanToValueRatio
2.87
CY2020Q4 mfin Loan To Value Ratio
LoanToValueRatio
3.27
CY2021Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
49039000
CY2021Q3 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
2482000
CY2021Q3 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-3194000
CY2021Q3 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-4525000
CY2021Q3 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-1258000
CY2021Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
42544000
CY2020Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
54560000
mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
13145000
mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-7713000
mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-8948000
mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-8500000
CY2021Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
42544000
CY2020Q2 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
47375000
CY2020Q3 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
13444000
CY2020Q3 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-1697000
CY2020Q3 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-426000
CY2020Q3 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-9954000
CY2020Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
48742000
CY2019Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
52711000
mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
25569000
mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-5984000
mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-2318000
mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-21236000
CY2020Q3 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
48742000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
451720000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
217403000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
317507000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
131798000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
203590000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
102750000
CY2021Q3 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1424768000
CY2020Q4 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1312005000
CY2021Q3 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0190
CY2021Q3 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7098000
CY2020Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
5805000
CY2021Q3 mfin Reserve Deposits
ReserveDeposits
750000
CY2020Q4 mfin Reserve Deposits
ReserveDeposits
250000
mfin Number Of Individual With Time Deposits Greater Than100000
NumberOfIndividualWithTimeDepositsGreaterThan100000
0
CY2021Q3 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
8738000000
CY2021Q3 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Or Less
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsOrLess
157023000
CY2021Q3 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Through Six Months
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsThroughSixMonths
89027000
CY2021Q3 us-gaap Contractual Maturities Time Deposits100000 Or More Six Months Through12 Months
ContractualMaturitiesTimeDeposits100000OrMoreSixMonthsThrough12Months
197616000
CY2021Q3 us-gaap Contractual Maturities Time Deposits100000 Or More After12 Months
ContractualMaturitiesTimeDeposits100000OrMoreAfter12Months
755139000
CY2021Q3 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
1198805000
CY2021Q1 us-gaap Notes Payable
NotesPayable
25000000
CY2021Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0725
CY2020Q4 us-gaap Notes Payable
NotesPayable
33600000
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
33485000
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25000000
CY2020Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
250000
CY2020Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-09-24
CY2020Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
16500000
CY2021Q3 mfin Capital Contribution Amount
CapitalContributionAmount
9500000
CY2021Q3 mfin Remaining Amount Of Debenture After Deducting Leverage Fee
RemainingAmountOfDebentureAfterDeductingLeverageFee
4750000000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2859000
CY2021Q1 us-gaap Notes Payable
NotesPayable
5207000
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1767000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
571000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
596000
us-gaap Operating Lease Cost
OperatingLeaseCost
1715000
us-gaap Operating Lease Cost
OperatingLeaseCost
1788000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
481000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
632000
us-gaap Operating Lease Payments
OperatingLeasePayments
1780000
us-gaap Operating Lease Payments
OperatingLeasePayments
1994000
CY2021Q3 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-41000
CY2020Q3 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-14000
mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-76000
mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-42000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10277000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11737000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2140000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2004000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9346000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11018000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11486000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13022000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M24D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0555
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0554
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13663000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2373000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2390000
CY2021Q3 mfin Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
3521000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
612000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2411000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2356000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2177000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
11486000
CY2021Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
44022000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
44799000
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
12550000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
19556000
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18745000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30493000
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
2309000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
1174000
CY2021Q3 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
10000
CY2020Q4 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
6769000
CY2021Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
10408000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
345000
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2295000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
462000
CY2021Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
12703000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
807000
CY2021Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
1833000
CY2021Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1359000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2154000
CY2021Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
721000
CY2020Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
83000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
991000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
306000
CY2021Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3198000
CY2020Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5940000
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
9252000
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-9239000
CY2021Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
889000
CY2020Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2524000
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
4176000
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3550000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6167000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8381000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16573000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12483000
CY2021Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4807000
CY2020Q3 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5967000
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11331000
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10034000
CY2021Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
942000
CY2020Q3 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1201000
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2217000
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1961000
CY2021Q3 mfin Income Tax Rate Reconciliation Valuation Allowance Against Net Operating Losses
IncomeTaxRateReconciliationValuationAllowanceAgainstNetOperatingLosses
0
mfin Income Tax Rate Reconciliation Valuation Allowance Against Net Operating Losses
IncomeTaxRateReconciliationValuationAllowanceAgainstNetOperatingLosses
1833000
CY2021Q3 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
110000
CY2020Q3 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-939000
us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
1479000
us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-790000
CY2021Q3 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
183000
CY2020Q3 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
522000
us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
449000
us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
356000
CY2021Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
132000
CY2020Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
211000
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-81000
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1000000
CY2021Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
359000
CY2020Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1841000
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
243000
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1922000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6167000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8381000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16573000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12483000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1186586
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
326116
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0097
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0146
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5398
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5018
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
550040
CY2019Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2019Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
13.53
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.58
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
444557
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.24
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
42928
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.91
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
951669
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.41
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
317398
CY2021Q1 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
6.79
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.79
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3984
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.89
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
768
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.79
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1264315
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.50
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
32446
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.98
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
22227
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.76
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1209642
CY2021Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2021Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.53
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1981
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.85
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
21075
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.34
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1186586
CY2021Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2021Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.55
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
326116
CY2021Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit
2.14
CY2021Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit
12.55
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.61
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
77000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y2M15D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
773362
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2020Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
152000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1590000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
463000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
317398
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Grants In Period Exercise Price Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsGrantsInPeriodExercisePricePerShare
6.79
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.79
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
2530
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit
6.55
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
7.25
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
6.96
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
185278
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit
6.55
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit
7.25
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.67
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
902952
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2021Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.50
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
33134
CY2021Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit
4.89
CY2021Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
7.25
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
5.99
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
8000
CY2021Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit
5.58
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
5.58
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
861818
CY2021Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2021Q2 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.53
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
1348
CY2021Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit
4.89
CY2021Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
7.25
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
5.40
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
860470
CY2021Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2021Q3 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.53
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
77000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
6
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
mfin Number Of Non Operating Segments
NumberOfNonOperatingSegments
2
CY2021Q3 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
41497000
CY2021Q3 mfin Interest Expense Net
InterestExpenseNet
7426000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
34071000
CY2021Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
-337000
CY2021Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
34408000
CY2021Q3 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
3335000
CY2021Q3 mfin Race Team Related Expense
RaceTeamRelatedExpense
2424000
CY2021Q3 mfin Non Interest Expense Income
NonInterestExpenseIncome
12428000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22891000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6167000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
16724000
CY2021Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1372233000
CY2021Q3 us-gaap Assets
Assets
1805234000
CY2021Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1424142000
CY2021Q3 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0373
CY2021Q3 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1981
CY2021Q3 mfin Interest Yield
InterestYield
0.1155
CY2021Q3 mfin Net Interest Margin
NetInterestMargin
0.0948
CY2021Q3 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0334
CY2021Q3 mfin Delinquency Status
DelinquencyStatus
0.0029
CY2021Q3 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0038
mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
115953000
mfin Interest Expense Net
InterestExpenseNet
23718000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
92235000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2000000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
90235000
mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
10153000
mfin Race Team Related Expense
RaceTeamRelatedExpense
7219000
mfin Non Interest Expense Income
NonInterestExpenseIncome
39210000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
53959000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16573000
us-gaap Profit Loss
ProfitLoss
37386000
CY2021Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1372233000
CY2021Q3 us-gaap Assets
Assets
1805234000
CY2021Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1424142000
mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0273
mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1447
mfin Interest Yield
InterestYield
0.1156
mfin Net Interest Margin
NetInterestMargin
0.0919
mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0334
CY2020Q3 mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
8962000
CY2020Q3 mfin Race Team Related Expense
RaceTeamRelatedExpense
2636000
CY2020Q3 mfin Non Interest Expense Income
NonInterestExpenseIncome
24047000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28414000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8381000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-20033000
CY2020Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1190544000
mfin Delinquency Status
DelinquencyStatus
0.0029
mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
-0.0117
CY2020Q3 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
37440000
CY2020Q3 mfin Interest Expense Net
InterestExpenseNet
8384000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
29056000
CY2020Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
39749000
CY2020Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-10693000
CY2020Q3 us-gaap Assets
Assets
1604275000
CY2020Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1271185000
CY2020Q3 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
-0.0569
CY2020Q3 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
-0.2977
CY2020Q3 mfin Interest Yield
InterestYield
0.1123
CY2020Q3 mfin Net Interest Margin
NetInterestMargin
0.0872
CY2020Q3 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0707
CY2020Q3 mfin Delinquency Status
DelinquencyStatus
0.0107
CY2020Q3 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0536
mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
108570000
mfin Interest Expense Net
InterestExpenseNet
26219000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
82351000
us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
73231000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
9120000
mfin Income From Sponsorship And Race Winnings
IncomeFromSponsorshipAndRaceWinnings
15161000
mfin Race Team Related Expense
RaceTeamRelatedExpense
6584000
mfin Non Interest Expense Income
NonInterestExpenseIncome
65479000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47782000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12483000
us-gaap Profit Loss
ProfitLoss
-35299000
CY2020Q3 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1190544000
CY2020Q3 us-gaap Assets
Assets
1604275000
CY2020Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1271185000
mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
-0.0343
mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
-0.1702
mfin Interest Yield
InterestYield
0.1131
mfin Net Interest Margin
NetInterestMargin
0.0858
mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0707
mfin Delinquency Status
DelinquencyStatus
0.0107
mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0330
mfin Employment Agreement Description
EmploymentAgreementDescription
Employment agreements expire at various dates through 2025
CY2021Q3 mfin Employment Agreements Future Minimum Payments Due
EmploymentAgreementsFutureMinimumPaymentsDue
10896000
CY2021Q3 us-gaap Trading Liabilities Fair Value Disclosure
TradingLiabilitiesFairValueDisclosure
0
CY2020Q4 us-gaap Trading Liabilities Fair Value Disclosure
TradingLiabilitiesFairValueDisclosure
336000
CY2021Q3 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-141000
mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-719000
CY2020 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-1013000
CY2018Q4 us-gaap Variable Interest Entity Initial Consolidation Gain Or Loss
VariableInterestEntityInitialConsolidationGainOrLoss
25325000

Files In Submission

Name View Source Status
0000950170-21-003478-index-headers.html Edgar Link pending
0000950170-21-003478-index.html Edgar Link pending
0000950170-21-003478.txt Edgar Link pending
0000950170-21-003478-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mfin-20210930.htm Edgar Link pending
mfin-20210930.xsd Edgar Link pending
mfin-20210930_cal.xml Edgar Link unprocessable
mfin-20210930_def.xml Edgar Link unprocessable
mfin-20210930_htm.xml Edgar Link completed
mfin-20210930_lab.xml Edgar Link unprocessable
mfin-20210930_pre.xml Edgar Link unprocessable
mfin-ex31_1.htm Edgar Link pending
mfin-ex31_2.htm Edgar Link pending
mfin-ex32_1.htm Edgar Link pending
mfin-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending